Enter your terms above and click the 'Search' button.

Showing articles 0 to 9 of 9 Filter Applied: multiple sclerosis,treatment of (Click to remove) Inhibition of CD40L with Frexalimab in Multiple Sclerosis NEJM 390:589-600, 662, Vermersch,P.,et al, 2024 Multiple Sclerosis Rebound Following Herpes Zoster Infection and Suspension of Fingolimod Neurol 79:2006-2007,1942, Gross, C.M.,et al, 2012 Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS Neurol 77:2010-2016, Kuhle, J.,et al, 2011 Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009 Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy NEJM 361:1081-1087, Linda,H.,et al, 2009 Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005 A Correlative Triad of Gadolinium-DTPA MRI, EDSS, & CSF-MBP in Relapsing MS Treated with High-Dose Intravenous Methylprednisolone Neurol 42:63-67, Barkhof,F.,et al, 1992 Intrathecal Interferon in Multiple Sclerosis Arch Neurol 39:609-615, Jacobs,L.,et al, 1982 Intraspinal Steroid Therapy Neurol 31:168-171, Bernat,J.L., 1981 Showing articles 0 to 9 of 9